top of page
The Professional Network for Healthcare Experts
Alcon acquires Neurotech Pharmaceuticals for $550 million to expand retinal disease portfolio
Alcon is acquiring Neurotech Pharmaceuticals for a reported $550 million, adding Encelto and an encapsulated-cell therapy platform to its retinal disease portfolio.
nuaxia
6 hours ago2 min read
OpenAI acquires Orchestra Bio to expand AI-powered drug development capabilities
OpenAI has acquired Orchestra Bio to strengthen its life-sciences AI capabilities and develop agent-based workflows for pharmaceutical research and development.
nuaxia
6 hours ago2 min read
Ambrose Healthcare acquires AM-Pharma in rare disease transaction worth up to €161 million
Ambrose Healthcare has acquired Netherlands-based AM-Pharma in a rare disease transaction worth up to €161 million, adding an investigational therapy for hypophosphatasia.
nuaxia
1 day ago2 min read
Merck KGaA agrees $1.3 billion acquisition of Silence Therapeutics to expand rare disease siRNA pipeline
Merck KGaA has agreed to acquire Silence Therapeutics in an all-cash transaction valued at approximately $1.3 billion in equity, expanding its RNA interference pipeline.
nuaxia
2 days ago2 min read
Alaunos acquires Velaris Therapeutics alongside $350 million financing for pulmonary hypertension pipeline
Alaunos Therapeutics has acquired Velaris Therapeutics in a stock-for-stock transaction supported by a separate $350 million financing to advance pulmonary hypertension treatments.
nuaxia
Oct 152 min read
bottom of page